UNSPSC 51102862: Oxytetracycline/polymyxin b

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE109. This VA Drug Class (DE109) classifies this compound as belonging to the group ANTI-INFECTIVE, TOPICAL, OTHER.

UNSPSC 51102862 Oxytetracycline/polymyxin b is a Commodity code nominally identifying a specific antibiotic combination product, but the recent state and local opportunities posted under this code show little alignment with that narrow pharmaceutical scope. The opportunities actually solicited span emergency medical supplies, direct-to-manufacturer pharmacy programs, and multi-source generic pharmaceuticals through cooperative purchasing vehicles—none of which center on oxytetracycline/polymyxin b specifically. State and local governments are using this code to tag broader pharmaceutical procurement, emergency response medical consumables, and pharmacy benefit program design work rather than discrete antibiotic purchases. The issuing bodies include city purchasing departments (Tampa), county health authorities (Seminole County, Florida), state health agencies (Texas Health and Human Services Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, serving participating states including Oregon).

Recent opportunities show activity across Florida, Texas, Minnesota, and Oregon. The City of Tampa's IFB 26P00145 (posted March 25, 2026, due March 13, 2026) solicited 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division—respiratory equipment, cardiac monitoring electrodes, endotracheal tubes, gloves, and oxygen delivery systems—with an estimated contract value of $700,000 and a Small Local Business Enterprise set-aside. Seminole County, Florida posted IFB 60459723LAS (posted June 30, 2026) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, potentially FEMA-funded. The Texas Health and Human Services Commission issued RFI HHS0017013 (posted April 3, 2026) to explore direct-to-manufacturer prescription program capabilities. The Minnesota Multistate Cooperative Purchasing Alliance issued RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products through authorized wholesalers. The code shows limited activity specifically matching its product name; buyers appear to be using it as a catch-all for pharmaceutical and medical supply procurement.